Ray Dalio Indicator Tells You To Avoid Apple Inc. (AAPL), Johnson & Johnson (JNJ) and Potash

During the first quarter Bridgewater acquired some 618,000 shares of Potash Corp./Saskatchewan (USA) (NYSE:POT) to take its stake in the company to 1.22 million shares valued at $39.31 million. The fund has held a stake in the $25.6 billion fertilizer company since the second quarter of 2014. So far this year, Potash Corp./Saskatchewan (USA) (NYSE:POT)’s stock has slid by almost 13%. On the other hand, the agricultural inputs industry is up by 6.77% during the same period.  The company offers a sizable dividend yield of almost 5%. However, it might not be the best idea to hold the stock just because of the yield, especially considering that TD Securities recently downgraded Potash Corp./Saskatchewan (USA) (NYSE:POT) to ‘Hold’ from ‘Buy’. Among the billionaires that we track, five had an aggregate investment of $151.93 million in the company. David Shaw is one of them, as the fund he founded, D E Shaw holds about 1.08 million shares of Potash Corp./Saskatchewan (USA) (NYSE:POT) valued at $34.75 million.

Dalio’s holding in the $272.15 billion healthcare company, Johnson & Johnson (NYSE:JNJ), was boosted by 203,800 shares during the first quarter, lifting the current stake to 268,093 shares valued at $26.97 million. So far this year, Johnson & Johnson (NYSE:JNJ)’s stock has slid by a little over 6%, which is worrisome given that the drug manufacturers industry has appreciated by 8.56% during the same period. We can see also that despite the gains in Apple, Dalio’s large-cap picks on the whole have not performed particularly well. Ken Fisher‘s Fisher Asset Management heads the list of Johnson & Johnson (NYSE:JNJ)’s investors that we track, owning some 10.46 million shares valued at $1.05 billion.

Disclosure: None